Circadian misalignment and reduced rest-activity amplitude are candidate phenotypes in insomnia disorder, warranting phenotype-stratified trials of circadian interventions.
This narrative review proposes that some insomnia patients have circadian misalignment, reduced rest-activity amplitude, increased sleep-timing variability, or abnormal light exposure, which may require circadian-targeted adjunctive treatments. It suggests a phenotyping framework combining sleep diaries, actigraphy, light exposure, DLMO, and core body temperature to distinguish CRSWD-dominant insomnia, insomnia with circadian modifiers, and comorbid insomnia and CRSWD. CBT-I remains first-line, with fixed wake time, morning light, evening light restriction, timed low-dose melatonin, and scheduled activity as candidate adjunctive modules for future phenotype-stratified trials.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Circadian misalignment and reduced rest-activity amplitude are candidate phenotypes in insomnia disorder, warranting phenotype-stratified trials of circadian interventions. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Circadian misalignment and reduced rest-activity amplitude are candidate phenotypes in insomnia disorder, warranting phenotype-stratified trials of circadian interventions.
This conclusion is most relevant to: Patients with insomnia disorder, potentially stratified into circadian phenotypes..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Circadian dimensions in insomnia disorder: mechanistic evidence, candidate phenotypes, and a phenotype-stratified research framework. (Frontiers in psychiatry, 2026) —
How It Works
The proposed biological pathway:
- ▸Insomnia is traditionally linked to hyperarousal and altered sleep homeostasis.
- ▸Two-process model indicates sleep depends on circadian phase, amplitude, and stability.
- ▸Some insomnia patients show circadian misalignment or reduced amplitude.
- ▸Proposed phenotyping framework to identify circadian subtypes.
- ▸Circadian-targeted adjuncts to CBT-I may improve outcomes in these subtypes.
Who Might Benefit
Evidence fit by population:
- ▸Patients with insomnia disorder, potentially stratified into circadian phenotypes.
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Narrative review, not systematic; may have selection bias.
- ▸Proposed phenotypes lack operational thresholds and validated cutoffs.
- ▸No prospective trials yet; predictive validity and incremental benefit unknown.
- ▸Measurement burden (DLMO, core body temperature) may limit clinical feasibility.
Frequently Asked Questions
What are the proposed circadian phenotypes in insomnia?▼
The review proposes three phenotypes: CRSWD-dominant insomnia complaints, insomnia disorder with circadian modifiers, and comorbid insomnia disorder and CRSWD.
What measurements are recommended for circadian phenotyping?▼
Sleep diaries, actigraphy, light exposure assessment, dim-light melatonin onset (DLMO), and core body temperature rhythms.
Is CBT-I still the first-line treatment for insomnia?▼
Yes, CBT-I remains first-line, but circadian-targeted adjuncts may be added for patients with circadian phenotypes.
What circadian interventions are proposed as adjuncts?▼
Fixed wake time, morning light, evening light restriction, timed low-dose melatonin, scheduled activity, and multicomponent approaches.
References
- 1.Zhang S, Liu Y, Tan J, Si W, Liu H, Huang Y, Li Y, Xiao J. “Circadian dimensions in insomnia disorder: mechanistic evidence, candidate phenotypes, and a phenotype-stratified research framework..” Frontiers in psychiatry, 2026. PMID: 42539544 DOI: 10.3389/fpsyt.2026.1884632